Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection after Failure of Pegylated Interferon and Ribavirin with an Earlier-Generation Protease Inhibitor: Final 24-Week Results from C-SALVAGE

  • Maria Buti
  • , Stuart C. Gordon
  • , Eli Zuckerman
  • , Eric Lawitz
  • , Jose L. Calleja
  • , Harald Hofer
  • , Christopher Gilbert
  • , John Palcza
  • , Anita Y.M. Howe
  • , Mark J. Dinubile
  • , Michael N. Robertson
  • , Janice Wahl
  • , Eliav Barr
  • , Xavier Forns

Research output: Contribution to journalArticlepeer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection after Failure of Pegylated Interferon and Ribavirin with an Earlier-Generation Protease Inhibitor: Final 24-Week Results from C-SALVAGE'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science